Filing Details
- Accession Number:
- 0000899866-13-000174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-26 16:59:25
- Reporting Period:
- 2013-09-24
- Filing Date:
- 2013-09-26
- Accepted Time:
- 2013-09-26 16:59:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1231954 | P Stephen Squinto | C/O Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire CT 06410 | Evp, Chief Global Ops. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.0001 Per Share | Disposition | 2013-09-24 | 304 | $112.54 | 105,186 | No | 4 | S | Indirect | By family trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By family trust |
Footnotes
- This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.